BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35076303)

  • 1. Defining Diagnostic Criteria for Prostatic Ductal Adenocarcinoma at Multiparametric MRI.
    Ranasinghe WKB; Troncoso P; Surasi DS; Ibarra Rovira JJ; Bhosale P; Szklaruk J; Kokorovic A; Wang X; Elsheshtawi M; Zhang M; Aparicio A; Chapin BF; Bathala TK
    Radiology; 2022 Apr; 303(1):110-118. PubMed ID: 35076303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy and Observer Agreement of the MRI Prostate Imaging for Recurrence Reporting Assessment Score.
    Pecoraro M; Turkbey B; Purysko AS; Girometti R; Giannarini G; Villeirs G; Roberto M; Catalano C; Padhani AR; Barentsz JO; Panebianco V
    Radiology; 2022 Aug; 304(2):342-350. PubMed ID: 35536130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Performance of
    Margel D; Bernstine H; Groshar D; Ber Y; Nezrit O; Segal N; Yakimov M; Baniel J; Domachevsky L
    Radiology; 2021 Nov; 301(2):379-386. PubMed ID: 34463555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
    Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
    J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram Models for Distinguishing Intraductal Carcinoma of the Prostate From Prostatic Acinar Adenocarcinoma Based on Multiparametric Magnetic Resonance Imaging.
    Yang L; Li XM; Zhang MN; Yao J; Song B
    Korean J Radiol; 2023 Jul; 24(7):668-680. PubMed ID: 37404109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of
    Lindenberg L; Mena E; Turkbey B; Shih JH; Reese SE; Harmon SA; Lim I; Lin F; Ton A; McKinney YL; Eclarinal P; Citrin DE; Dahut W; Madan R; Wood BJ; Krishnasamy V; Chang R; Levy E; Pinto P; Eary JF; Choyke PL
    Radiology; 2020 Sep; 296(3):564-572. PubMed ID: 32633674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies.
    Ranasinghe W; Shapiro DD; Hwang H; Wang X; Reichard CA; Elsheshtawi M; Achim MF; Bathala T; Tang C; Aparicio A; Tu SM; Navone N; Thompson TC; Pisters L; Troncoso P; Davis JW; Chapin BF
    Eur Urol; 2021 Feb; 79(2):298-306. PubMed ID: 33279304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section Histopathology.
    Tan N; Margolis DJ; Lu DY; King KG; Huang J; Reiter RE; Raman SS
    AJR Am J Roentgenol; 2015 Jul; 205(1):W87-92. PubMed ID: 26102423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the diagnosis and management of ductal prostate cancer.
    Ranasinghe W; Shapiro DD; Zhang M; Bathala T; Navone N; Thompson TC; Broom B; Aparicio A; Tu SM; Tang C; Davis JW; Pisters L; Chapin BF
    Nat Rev Urol; 2021 Jun; 18(6):337-358. PubMed ID: 33824525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
    Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
    Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraprostatic Tumor Extension: Comparison of Preoperative Multiparametric MRI Criteria and Histopathologic Correlation after Radical Prostatectomy.
    Park KJ; Kim MH; Kim JK
    Radiology; 2020 Jul; 296(1):87-95. PubMed ID: 32368959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).
    Gaur S; Harmon S; Gupta RT; Margolis DJ; Lay N; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Shih JH; Choyke PL; Turkbey B
    Acad Radiol; 2019 Jan; 26(1):5-14. PubMed ID: 29705281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate magnetic resonance imaging: The truth lies in the eye of the beholder.
    Riney JC; Sarwani NE; Siddique S; Raman JD
    Urol Oncol; 2018 Apr; 36(4):159.e1-159.e5. PubMed ID: 29336979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment.
    Schelb P; Kohl S; Radtke JP; Wiesenfarth M; Kickingereder P; Bickelhaupt S; Kuder TA; Stenzinger A; Hohenfellner M; Schlemmer HP; Maier-Hein KH; Bonekamp D
    Radiology; 2019 Dec; 293(3):607-617. PubMed ID: 31592731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative Predictive Value of Prostate Multiparametric Magnetic Resonance Imaging among Men with Negative Prostate Biopsy and Elevated Prostate Specific Antigen: A Clinical Outcome Retrospective Cohort Study.
    Lo G; Burton KR; Haider MA; Fleshner N; Finelli A; Ghai S
    J Urol; 2019 Dec; 202(6):1159-1165. PubMed ID: 31188731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic ductal adenocarcinoma: an aggressive tumour variant unrecognized on T2 weighted magnetic resonance imaging (MRI).
    Schieda N; Coffey N; Gulavita P; Al-Dandan O; Shabana W; Flood TA
    Eur Radiol; 2014 Jun; 24(6):1349-56. PubMed ID: 24687527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of
    Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
    BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of transition zone prostate cancer using T2-weighted (T2W) MRI: comparison of subjective features and quantitative shape analysis.
    Krishna S; Schieda N; McInnes MD; Flood TA; Thornhill RE
    Eur Radiol; 2019 Mar; 29(3):1133-1143. PubMed ID: 30105411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.